Drug
TD 1473
TD 1473: highest development phase Phase 1, developed by Theravance Biopharma. 3 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Theravance Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| TD-1473 oral capsule NCT03408470 | Phase 1 | Intestinal Disorders |
| TD-1473 NCT03555617 | Phase 1 | Inflammatory Bowel Disease |
| TD-1473 NCT02818686 | Phase 1 | Ulcerative Colitis, Active Moderate |
Latest
No recent events.
Follow TD 1473 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.